Literature DB >> 22095525

Intraluminal pH and goblet cell density in Barrett's esophagus.

Dimitrios Theodorou1, Shahin Ayazi, Steven R DeMeester, Joerg Zehetner, Christian G Peyre, Kimberly S Grant, Florian Augustin, Daniel S Oh, John C Lipham, Parakrama T Chandrasoma, Jeffrey A Hagen, Tom R DeMeester.   

Abstract

INTRODUCTION: Goblet cells in Barrett's esophagus (BE) vary in their density within the Barrett's segment. Exposure of Barrett's epithelium to bile acids is a major stimulant for goblet cell formation. The dissociation of bile acids into forms that penetrate Barrett's epithelium is known to be pH dependent. We hypothesized that variations in the esophageal luminal pH environment explains the variability in goblet cell density. The aim of this study was to correlate esophageal luminal pH with goblet cell density in patients with BE.
METHODS: A customized six-sensor pH catheter was positioned with the most distal sensor in the stomach and the remaining sensors located 1 cm below and 1, 3, 5, and 8 cm above the upper border of the lower esophageal sphincter in five normal subjects and six patients with long-segment BE. The luminal pH was measured by each sensor for 24-h and expressed as median pH. Patients with BE had four quadrant biopsies at levels corresponding to the location of the pH sensors. Goblet cell density was graded from 0 to 3 based on the number per high-power field.
RESULTS: In normal subjects, the median pH values recorded in the sensors within the lower esophageal sphincter (LES) and esophageal body were all above 5. In patients with BE, the median pH recorded by the sensor within the LES was 2.8 and increased progressively to 4.7 in the sensor at 8 cm above the LES. Goblet cell density was significantly lower in the distal Barrett's segment exposed to a median pH of 2.2 and increased in the proximal Barrett's segment exposed to a median pH of 4.4 (p = 0.003).
CONCLUSION: Patients with BE have a goblet cell gradient that correlates directly with an esophageal luminal pH gradient. This suggests that goblet cell differentiation is pH dependent and likely due to the effect of pH on bile acid dissociation.

Entities:  

Mesh:

Year:  2011        PMID: 22095525     DOI: 10.1007/s11605-011-1776-3

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  17 in total

1.  Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus.

Authors:  Richard E Sampliner
Journal:  Am J Gastroenterol       Date:  2002-08       Impact factor: 10.864

2.  Proton pump inhibitors reduce cell cycle abnormalities in Barrett's esophagus.

Authors:  M Umansky; W Yasui; A Hallak; S Brill; I Shapira; Z Halpern; H Hibshoosh; J Rattan; S Meltzer; E Tahara; N Arber
Journal:  Oncogene       Date:  2001-11-29       Impact factor: 9.867

3.  Predictive factors of Barrett esophagus: multivariate analysis of 502 patients with gastroesophageal reflux disease.

Authors:  G M Campos; S R DeMeester; J H Peters; S Oberg; P F Crookes; J A Hagen; C G Bremner; L F Sillin; R J Mason; T R DeMeester
Journal:  Arch Surg       Date:  2001-11

4.  COX2 expression, angiogenesis, proliferation and survival in Barrett's cancer.

Authors:  C Möbius; H J Stein; C Spiess; I Becker; M Feith; J Theisen; P Gais; U Jütting; J R Siewert
Journal:  Eur J Surg Oncol       Date:  2005-09       Impact factor: 4.424

5.  Epidermal growth factor receptor (EGFR) is overexpressed in high-grade dysplasia and adenocarcinoma of the esophagus and may represent a biomarker of histological progression in Barrett's esophagus (BE).

Authors:  James Cronin; Elizabeth McAdam; Antonios Danikas; Chris Tselepis; Paul Griffiths; John Baxter; Linzi Thomas; James Manson; Gareth Jenkins
Journal:  Am J Gastroenterol       Date:  2010-12-14       Impact factor: 10.864

6.  The mutagenic potential of duodenoesophageal reflux.

Authors:  Jörg Theisen; Jeffrey H Peters; Martin Fein; Michael Hughes; Jeffrey A Hagen; Steven R Demeester; Tom R Demeester; Peter W Laird
Journal:  Ann Surg       Date:  2005-01       Impact factor: 12.969

7.  Pathogenesis of Barrett esophagus: deoxycholic acid up-regulates goblet-specific gene MUC2 in concert with CDX2 in human esophageal cells.

Authors:  Yingchuan Hu; Carolyn Jones; Oliver Gellersen; Valerie A Williams; Thomas J Watson; Jeffrey H Peters
Journal:  Arch Surg       Date:  2007-06

8.  Measurement of gastric pH in ambulatory esophageal pH monitoring.

Authors:  Shahin Ayazi; Jessica M Leers; Arzu Oezcelik; Emmanuele Abate; Christian G Peyre; Jeffrey A Hagen; Steven R DeMeester; Farzaneh Banki; John C Lipham; Tom R DeMeester; Peter F Crookes
Journal:  Surg Endosc       Date:  2008-12-06       Impact factor: 4.584

9.  Bile acid accumulation by rabbit esophageal mucosa.

Authors:  E J Schweitzer; B L Bass; S Batzri; J W Harmon
Journal:  Dig Dis Sci       Date:  1986-10       Impact factor: 3.199

10.  Day-to-day discrepancy in Bravo pH monitoring is related to the degree of deterioration of the lower esophageal sphincter and severity of reflux disease.

Authors:  Shahin Ayazi; Jeffrey A Hagen; Joerg Zehetner; Farzaneh Banki; Florian Augustin; Ali Ayazi; Steven R DeMeester; Daniel S Oh; Helen J Sohn; John C Lipham; Tom R DeMeester
Journal:  Surg Endosc       Date:  2011-02-27       Impact factor: 4.584

View more
  13 in total

Review 1.  Barrett's Esophagus: A Comprehensive and Contemporary Review for Pathologists.

Authors:  Bita V Naini; Rhonda F Souza; Robert D Odze
Journal:  Am J Surg Pathol       Date:  2016-05       Impact factor: 6.394

Review 2.  Barrett oesophagus: lessons on its origins from the lesion itself.

Authors:  Stuart A C McDonald; Danielle Lavery; Nicholas A Wright; Marnix Jansen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2014-11-04       Impact factor: 46.802

3.  The Durability of Endoscopic Therapy for Treatment of Barrett's Metaplasia, Dysplasia, and Mucosal Cancer After Nissen Fundoplication.

Authors:  Corey S Johnson; Brian E Louie; Aaron Wille; Christy M Dunst; Stephanie G Worrell; Steven R DeMeester; Jessica Reynolds; Joe Dixon; John C Lipham; Michal Lada; Jeffrey H Peters; Thomas J Watson; Alexander S Farivar; Ralph W Aye
Journal:  J Gastrointest Surg       Date:  2015-03-05       Impact factor: 3.452

4.  Early Barrett esophagus-related neoplasia in segments 1 cm or longer is always associated with intestinal metaplasia.

Authors:  Benjamin Michael Allanson; Jessica Bonavita; Bob Mirzai; Tze Sheng Khor; Spiro C Raftopoulos; Willem Bastiaan de Boer; Ian S Brown; Marian Priyanthi Kumarasinghe
Journal:  Mod Pathol       Date:  2017-05-26       Impact factor: 7.842

Review 5.  Does anti-reflux surgery disrupt the pathway of Barrett's esophagus progression to cancer?

Authors:  Sebastian F Schoppmann; Ivan Kristo; Martin Riegler
Journal:  Transl Gastroenterol Hepatol       Date:  2018-12-05

Review 6.  Review on novel concepts of columnar lined esophagus.

Authors:  Johannes Lenglinger; Stephanie Fischer See; Lukas Beller; Enrico P Cosentini; Reza Asari; Fritz Wrba; Martin Riegler; Sebastian F Schoppmann
Journal:  Wien Klin Wochenschr       Date:  2013-09-06       Impact factor: 1.704

Review 7.  Histology of Barrett's Metaplasia: Do Goblet Cells Matter?

Authors:  Robert Odze
Journal:  Dig Dis Sci       Date:  2018-08       Impact factor: 3.199

Review 8.  Evolutionary dynamics in Barrett oesophagus: implications for surveillance, risk stratification and therapy.

Authors:  Melissa Schmidt; Richard J Hackett; Ann-Marie Baker; Stuart A C McDonald; Michael Quante; Trevor A Graham
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-11-02       Impact factor: 46.802

Review 9.  The Barrett's Gland in Phenotype Space.

Authors:  Stuart A C McDonald; Trevor A Graham; Danielle L Lavery; Nicholas A Wright; Marnix Jansen
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2014-11-12

10.  The stem cell organisation, and the proliferative and gene expression profile of Barrett's epithelium, replicates pyloric-type gastric glands.

Authors:  Danielle L Lavery; Anna M Nicholson; Richard Poulsom; Rosemary Jeffery; Alia Hussain; Laura J Gay; Janusz A Jankowski; Sebastian S Zeki; Hugh Barr; Rebecca Harrison; James Going; Sritharan Kadirkamanathan; Peter Davis; Timothy Underwood; Marco R Novelli; Manuel Rodriguez-Justo; Neil Shepherd; Marnix Jansen; Nicholas A Wright; Stuart A C McDonald
Journal:  Gut       Date:  2014-02-18       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.